A self-reported specialty is a claim, not a credential. This paper is a vendor-neutral guide to the discipline that separates a defensible physician sample from a list — an evidence ladder from self-report to primary-source registry match, where verification happens across the respondent lifecycle, and how credentialing differs across EU, UK, and US markets.
CatalystMR Research Team. (2026). Credible Physician Sample — Verifying Healthcare-Professional Credentials. CatalystMR Methodology Papers. https://www.catalystmr.com/insights/methodology-papers/physician-sample-verification/
@techreport{catalystmr_physician_sample_verification,
author={{CatalystMR Research Team}},
title={Credible Physician Sample — Verifying Healthcare-Professional Credentials},
institution={CatalystMR}, year={2026}, type={Methodology Paper},
url={https://www.catalystmr.com/insights/methodology-papers/physician-sample-verification/}
}TY - RPRT AU - CatalystMR Research Team TI - Credible Physician Sample — Verifying Healthcare-Professional Credentials PB - CatalystMR PY - 2026 UR - https://www.catalystmr.com/insights/methodology-papers/physician-sample-verification/ ER -
Healthcare research informs decisions — drug launches, device positioning, formulary strategy — that carry consequences far beyond the cost of the study. The variable that most often decides whether an HCP data file can be trusted is not how the audience was specified or how feasibility was modelled, but whether each respondent's professional credentials were genuinely verified — or merely self-reported and accepted.
This paper concentrates on that one discipline. It sets out a four-tier evidence ladder from unverified self-report to primary-source registry match; shows where verification has to happen across the respondent lifecycle for credentials to stay current; and maps how credentialing infrastructure differs across EU, UK, and US markets — so a buyer fielding internationally knows what "verified" should mean in each. Audience specification, feasibility, mode choice, and post-field QC are covered in companion papers; here they appear only where credential verification touches them.
A respondent who selects "cardiologist" from a dropdown has made a claim. Whether that claim is true is the single question on which an HCP study's credibility rests, and it is answered not by the screener but by verification — testing the claim against independent professional evidence. Three features of healthcare sample make that discipline non-negotiable.
Qualified clinicians are a small, high-value slice of any panel, and the incentive to complete a specialist study is exactly the pressure that tempts a near-miss respondent to round their role up to the target specialty. Where eligibility rests on unverified self-report, that pressure quietly inflates the qualifying population with people who do not belong in it.1
A motivated respondent can recognise the clinical language a screener seems to reward and select it without holding the credential behind it. Trap questions help, but the durable answer is to anchor eligibility to evidence that exists independently of the survey — a licence, a registry entry, a board certification — rather than to the respondent's account of themselves.
In a large consumer tracker, a few bad completes barely move the result. In a study of a narrow specialist cell, a single fabricated or misclassified respondent can visibly distort a finding that informs a clinical or commercial decision. The rarer the audience, the more each completion has to be earned through verification — not assumed.
"Verified" is used loosely in sample procurement. The useful question is not whether a provider verifies, but against what evidence. The four rungs below run from the weakest basis for eligibility to the strongest; each rung up is harder to fake and more defensible to a stakeholder.
The credential is matched against an authoritative external register — a national medical-council listing, a provider registry, or a board-certification record — independent of anything the respondent typed. The strongest basis, and the one a defensible HCP file is built on.
The respondent supplies a verifiable artefact — a licence or registration number, a provider identifier — that can be checked against a primary source. Stronger than assertion, but only as good as the check that follows it.
Self-reported specialty reconciled against data the panel already holds — prior profiling, response history, consistency traps. Catches drift and contradiction, but still rests on earlier self-report.
A specialty chosen from a dropdown, accepted as fielded. Adequate for broad consumer work; insufficient on its own wherever clinical accuracy drives the decision.
Decide the minimum tier your study requires before fielding, and write it into the spec. A broad attitudinal survey of clinicians may live safely at Tier 1; a study naming a subspecialty, or one informing a regulatory or commercial decision, belongs at Tier 3. The mistake is discovering only at analysis that "verified" meant Tier 0.
Reaching Tier 3 once is not enough, because a credential's accuracy decays as clinicians change roles, settings, and focus. The most defensible HCP programs verify at three points in the respondent lifecycle, each catching what the others cannot.
Match the credential to a primary source when the clinician joins — before any study creates an incentive to misrepresent.
Cross-check screener answers against the stored credential record, and catch clinical inconsistency as it happens.
Inspect finished data for clinically implausible, inattentive, or duplicated responses before delivery.
Recruitment-time verification is the strongest single check, because the respondent has no study-specific reason to misrepresent — but it ages the moment a clinician changes specialty emphasis or practice setting. Entry-time cross-validation catches that drift against the current screener; post-field auditing inspects behaviour rather than claims, catching the inattentive or fabricated completion that a valid credential cannot rule out. No single layer is sufficient; the combination is what makes the file defensible.2 Post-field quality control is itself a deep topic — Paper No. 137 sets out the full eleven-point framework.
Tier-3 verification depends on what authoritative register exists in a given country — and they differ. A buyer fielding internationally should expect a provider to name the specific source it verifies against in each market, and to conduct healthcare research under a recognised healthcare-MR code. In Europe, the EphMRA Code of Conduct is the sector's self-regulation framework for primary and secondary healthcare market research, complementing the ICC/ESOMAR Code.3
Ask: "In each market in my study, what register do you verify against, and what tier of evidence does that give me?" A credible international provider answers market by market — and is candid where a country offers no accessible primary source, rather than implying uniform Tier-3 everywhere.
Verification is not a one-time stamp; it is a state that decays. Clinicians move between settings, shift subspecialty emphasis, retire, or change prescribing authority — and a panel that verified them at join may be carrying records that no longer match reality. Maintaining credential integrity is its own discipline.
A valid credential does not guarantee an attentive, genuine response. AI-generated open-ends can now mimic clinical phrasing and pass naïve exact-match checks, which is why clinically-aware human review of verbatims — not just trap questions — belongs in any serious HCP programme. The ESOMAR Guideline for Online Research and the ICC/ESOMAR Code emphasise human oversight of automated processes for exactly this reason.4
The discipline reduces to a short set of habits — and a matching set of traps to avoid. These are specific to credential verification; the companion papers below carry the specification, feasibility, mode, and QC questions, so nothing here repeats them.
Physician sample earns its credibility one credential at a time. Decide the evidence tier each study needs and write it into the spec; verify against a primary source wherever clinical accuracy drives the decision; check at recruitment, entry, and post-field rather than once; name the register used in every market; and keep verification current rather than treating it as a permanent stamp. Do that, and the data file rests on evidence instead of assertion. The EphMRA, ESOMAR, and ISO 20252 frameworks exist precisely so buyers can ask for this rigour in consistent terms — and recognise it when they see it.1,3
CatalystMR is a global market-research panel and fieldwork partner specialising in hard-to-reach healthcare, B2B, and niche audiences. We verify clinical credentials against primary sources, re-verify over time, and pair verified online sample with live telephone (CATI) capability for the specialties online alone cannot reach — under one screener, one QC standard, and one point of contact.
We publish our own responses to ESOMAR's 37 Questions and design credential verification into every HCP engagement rather than treating quality as a post-field cleanup.
Compliance posture: our methodology is aligned to the ESOMAR Code and Guidelines, the EphMRA Code, and the ISO 20252 framework, and we are certified under the EU–U.S., UK, and Swiss Data Privacy Frameworks, with personal data siloed from response data.